The value of 18F-FDG PET/CT in predicting the response to PD-1 blocking immunotherapy in advanced NSCLC patients with high-level PD-L1 expression

K Vekens, H Everaert, B Neyns, B Ilsen, L Decoster - Clinical lung cancer, 2021 - Elsevier
Background The objective of this study was to evaluate if 18 F-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT)-derived parameters are …
被引用次数：17 相关文章

The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression

K Vekens, H Everaert, B Neyns, B Ilsen… - Clinical lung …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The objective of this study was to evaluate if 18 F-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT)-derived parameters are …

The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression

K Vekens, H Everaert, B Neyns, B Ilsen… - Clinical Lung …, 2021 - clinical-lung-cancer.com
Background The objective of this study was to evaluate if 18 F-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT)-derived parameters are …

The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression

K Vekens, H Everaert, B Neyns, B Ilsen… - Clinical lung …, 2021 - researchportal.vub.be
BACKGROUND: The objective of this study was to evaluate if 18F-fluorodeoxyglucose
positron emission tomography/computed tomography (18F-FDG PET/CT)-derived …

The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression.

K Vekens, H Everaert, B Neyns, B Ilsen… - Clinical Lung …, 2021 - europepmc.org
Background The objective of this study was to evaluate if 18 F-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT)-derived parameters are …